JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2005) 185, 235-242       DOI: 10.1677/joe.1.06014
© 2005 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markides, C S A
Right arrow Articles by Liehr, J G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markides, C S A
Right arrow Articles by Liehr, J G

Specific binding of 4-hydroxyestradiol to mouse uterine protein: evidence of a physiological role for 4-hydroxyestradiol

C S A Markides and J G Liehr

The Stehlin Foundation for Cancer Research, 1918 Chenevert St, Houston, TX 77003, USA

(Requests for offprints should be addressed to C S A Markides; Email: cmarkides{at}stehlin.org)

There are several indications of a possible physiological role for 4-hydroxyestradiol (4-OHE2) in hormone-responsive tissues. To examine a hormonal activity of 4-OHE2, we have studied the binding of 3H-labeled 4-OHE2 to mouse uterine cytosolic protein. In uteri of 3-week-old mice, total binding was 319.4 ± 13.9 fmol/mg protein. Binding in the presence of excess unlabeled 4-OHE2 dropped to 82.1 ± 1.7 fmol/mg protein, whereas 214.6 ± 9.4 fmol/mg protein bound while incubating in an excess of unlabeled 17ß-estradiol (E2). The difference between the two binding values in the presence of excess steroid (132.5 ± 11.1 fmol/mg protein) is taken as selective binding of 4-OHE2 to a specific protein. In mice older than 4 weeks, the specific 4-OHE2 binding declined: 32.0 ± 4.0 fmol/mg protein at 8 weeks, 54.8 ± 6.3 fmol/mg protein at 12 weeks and 54.6 ± 5.2 fmol/mg protein at 9 months. Of other organs tested (liver, kidney, lung and whole brain) only lung showed significant selective binding of 4-OHE2. When E2-binding sites are blocked, binding follows first-order kinetics, yielding a dissociation constant (Kd) value of 11.8 ± 2.1 nM. The specific binding of 4-OHE2 was not inhibited by any other steroids or estrogen metabolites that were tested, except for 2-hydroxyestradiol (2-OHE2), which displayed competitive inhibition of 4-OHE2 binding with an inhibition constant (Ki) value of 98.2 ± 12.6 nM. These results lead us to conclude that 4-OHE2 binds to a specific binding protein, distinct and different from binding to estrogen receptors (ER{alpha} and ERß). The physiological role of this binding remains to be elucidated.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.